Anagrelide
In the US, Anagrelide (anagrelide systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Chronic Myelogenous Leukemia and Thrombocythemia.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XX35
CAS registry number (Chemical Abstracts Service)
0068475-42-3
Chemical Formula
C10-H7-Cl2-N3-O
Molecular Weight
256
Therapeutic Category
Antiplatelet agent: Phosphodiesterase inhibitor
Chemical Name
6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one (WHO)
Foreign Names
- Anagrelidum (Latin)
- Anagrelid (German)
- Anagrelide (French)
- Anagrelida (Spanish)
Generic Names
- Anagrelide (OS: BAN)
- Anagrelide Hydrochloride (OS: USAN)
- BL 4162A (IS: Bristol-Myers)
- BMY 26538-01 (IS)
Brand Names
- Thromboreductin
Dem Ilaç, Turkey; Orpha-Devel, Romania; Orphan, Poland - Xagrid
Shire, Spain; Shire, Greece; Shire, Ireland - Agrelid
Ariston, Argentina - Agrylin
Fahrenheit, Indonesia; Mallinckrodt, Israel; Mallinckrodt, Taiwan; Shire, Australia; Shire, Canada; Shire, Hong Kong; Shire, Philippines; Shire, United States; Tema Medical, South Africa; Yuhan, South Korea - Anagrelide Hydrochloride Alphapharm
Alphapharm, United States - Anagrelide Hydrochloride Barr
Barr, United States - Anagrelide Hydrochloride Impax
Impax, United States - Anagrelide Hydrochloride Ivax
Teva, United States - Anagrelide Hydrochloride Mylan
Mylan, United States - Anagrelide Hydrochloride Watson
Watson, United States - Anagrelide
Healthcare Logistics, New Zealand - Gen-Anagrelide
Genpharm ULC, Canada - PMS-Anagrelide
Pharmascience, Canada - Sandoz Anagrelide
Sandoz, Canada - Thromboreductin
AOP, Malaysia; AOP, Serbia; AOP Orphan, Bulgaria; AOP Orphan, Indonesia; Combiphar, Indonesia; Hospira, Hong Kong; Hospira, Malaysia; Hospira, Thailand; Key Oncologics, South Africa; OrPha, Switzerland; Orpha Devel, Czech Republic; Orpha Devel, Latvia; Orpha Devel, Slovenia; Orpha-Devel, Austria; Orpha-Devel, Lithuania; Providens, Croatia (Hrvatska) - Tromboreductin
AOP Orphan, Bulgaria - Xagrid
Opopharma, Switzerland; Shire, Belgium; Shire, Germany; Shire, Denmark; Shire, France; Shire, United Kingdom; Shire, Italy; Shire, Lithuania; Shire, Latvia; Shire, Netherlands; Shire, Norway; Shire Human Genetic Therapies AB, Portugal; Swedish Orphan, Finland; Swedish Orphan Biovitrum, Sweden
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
